Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Viz.ai, founded in 2016 and headquartered in San Francisco, California, is a pioneering company in the healthcare technology sector. The company specializes in using artificial intelligence (AI) to enhance medical imaging analysis and streamline care coordination, particularly in time-sensitive conditions like strokes. Viz.ai's platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment.
The company has shown impressive growth, with its AI-powered solutions now being used in over 1,500 U.S. hospitals, including most of the top 50 healthcare systems. Viz.ai's user base grew by nearly 30% in 2023, reaching 45,000 healthcare providers. The company's annual recurring revenue (ARR) has been roughly doubling each year, with expectations to reach $100 million in 2024, up from $12 million in 2020.
Viz.ai has attracted significant investment, raising a total of $289.19 million across multiple funding rounds. Its most recent Series D round in April 2022 raised $100 million, valuing the company at $1.2 billion. Notable investors include GV (Alphabet's venture arm), Tiger Global Management, and Kleiner Perkins.
While there are no official announcements or confirmed plans regarding an initial public offering (IPO) for Viz.ai, the company's rapid growth, substantial funding, and innovative technology in the expanding AI healthcare market could potentially position it for future public market considerations. However, any discussions about a potential IPO remain speculative at this time.
Factors that could influence any future IPO decisions might include Viz.ai's continued revenue growth, market conditions in the healthcare technology sector, and the company's strategic goals for expansion. The appointment of Michael Herring, an experienced financial executive, as Chief Financial Officer in March 2024 could also be seen as a step towards strengthening the company's financial leadership.
It's important to note that without official statements from Viz.ai or its representatives, any IPO prospects remain uncertain. Investors interested in Viz.ai should continue to monitor official company announcements for the most accurate and up-to-date information regarding any potential public offering plans.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Viz.ai's IPO prospects remain uncertain, investors eager to gain exposure to innovative AI-driven healthcare technology don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO companies like Viz.ai, potentially allowing you to benefit from their growth before they go public. Our platform provides opportunities to diversify your portfolio with lower minimum investments in emerging leaders in the healthcare and AI sectors.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
